Marion v. Searle
Executive Summary
In a Sept. 25 complaint, Cardizem manufacturer asked Kansas City, Mo. Federal Court for injunction against comparative ads with "false, misleading and deceptive" claims that Searle's Calan dosage is 240 mg per day, whereas Cardizem's is 180 mg twice daily. Marion argues that Calan is prescribed at "higher than 240 mg per day" while Cardizem's dosage is 90 mg b.i.d.